MyMD Pharmaceuticals Inc (MYMD)
2.895
-0.16
(-5.39%)
USD |
NASDAQ |
May 07, 11:14
MyMD Pharmaceuticals Shareholders Equity (Quarterly): 12.37M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.37M |
| September 30, 2023 | 16.11M |
| June 30, 2023 | 10.74M |
| March 31, 2023 | 13.09M |
| December 31, 2022 | 14.70M |
| September 30, 2022 | 18.33M |
| June 30, 2022 | 16.12M |
| Date | Value |
|---|---|
| March 31, 2022 | 19.62M |
| December 31, 2021 | 23.65M |
| September 30, 2021 | 25.89M |
| June 30, 2021 | 31.07M |
| March 31, 2021 | 33.42M |
| December 31, 2020 | -5.257M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-5.257M
Minimum
Dec 2020
33.42M
Maximum
Mar 2021
17.68M
Average
16.12M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Acrivon Therapeutics Inc | 121.20M |
| Vincerx Pharma Inc | 11.22M |
| CEL-SCI Corp | 12.65M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.86M |
| Total Liabilities (Quarterly) | 5.493M |